- Page 2 and 3:
Co-chairs of the conference: Janko
- Page 4 and 5:
Table of Contents Conference Progra
- Page 6 and 7:
12:40 - 12:55 Irina Kondakova: Matr
- Page 8 and 9:
18:15 - 18:40 Ib Jarle Christensen:
- Page 11 and 12:
Abstracts of Lectures
- Page 13 and 14:
inhibitor of metalloproteinases-1 i
- Page 15 and 16:
Tyrosine kinase inhibitors increase
- Page 17 and 18:
Cancer gene therapy by electrotrans
- Page 19 and 20:
effect of tamoxifen. From a clinica
- Page 21 and 22:
Cox-2 is a target gene of Rho GDP d
- Page 23 and 24:
Cancer preventive potential of xant
- Page 25 and 26:
Gene expression regulation by siRNA
- Page 27 and 28:
Aptamer-based capture molecular as
- Page 29 and 30:
The expression pattern of the uroki
- Page 31 and 32:
Tumour vascular disrupting agents:
- Page 33 and 34:
Matrix metalloproteinases, their ti
- Page 35 and 36:
Altered expression of cysteine cath
- Page 37 and 38:
l22 37 Adult stem cells: from bench
- Page 39 and 40:
l24 39 Specific laboratory animal h
- Page 41 and 42:
The pharmacogenetic basis for indiv
- Page 43 and 44:
Mechanisms in metastasis Ruth J. Mu
- Page 45 and 46:
The lymphatic ring assay: a new in
- Page 47 and 48:
The use of immuno-nanoparticles for
- Page 49 and 50:
after antiangiogenic strategies, su
- Page 51 and 52:
The role of integrative genomics/pr
- Page 53 and 54:
Effect of the tumour microenvironme
- Page 55 and 56:
Addressing the angiogenic switch by
- Page 57 and 58:
Genetic predisposition on breast ca
- Page 59 and 60:
Kallikrein-related peptidases: nove
- Page 61 and 62:
Vascular disrupting action of elect
- Page 63 and 64:
Cysteine cathepsins in tumors and t
- Page 65 and 66:
Cysteine cathepsins and stefins in
- Page 67 and 68:
l50 67 Time dependence of electric
- Page 69 and 70:
Melanoma genomics and molecular tar
- Page 71 and 72:
Response to VEGF receptor inhibitio
- Page 73 and 74:
l55 73 Chemotherapy-induced cell de
- Page 75 and 76:
Towards high throughput, high conte
- Page 77:
l59 77 Mechanisms of proteolytic tu
- Page 80 and 81:
List of Posters P1. Tina Batista Na
- Page 82 and 83:
P37. Geoffrey J. Pilkington: CD44 a
- Page 84 and 85:
Mistletoe extract triggers mitochon
- Page 86 and 87:
Glioma: combating the invasive cell
- Page 88 and 89:
Protease inhibitory and cytotoxic e
- Page 90 and 91:
Delivery of meta-tetra(hydroxypheny
- Page 92 and 93:
Platinum analogue trans-[PtCl 2 (3-
- Page 94 and 95:
Reduction of plasminogen activity i
- Page 96 and 97: Cysteine cathepsins and their endog
- Page 98 and 99: The influence of Mg ions on the eff
- Page 100 and 101: Dimerization of endogenous MT1-MMP
- Page 102 and 103: Chemical acylation improves membran
- Page 104 and 105: Comparison of the results for the J
- Page 106 and 107: Tumor blood flow modifying changes
- Page 108 and 109: Sodium iodide method is suitable fo
- Page 110 and 111: Gene transfer into solid tumors by
- Page 112 and 113: Reversal of thiopurine cytotoxicity
- Page 114 and 115: Quantification of viability in orga
- Page 116 and 117: Electrochemotherapy of cutaneous me
- Page 118 and 119: Cytotoxic and genotoxic influence o
- Page 120 and 121: Antiproliferative and adhesion-stim
- Page 122 and 123: Mushrooms as a source of antitumour
- Page 124 and 125: Avoiding systemic toxicity of the T
- Page 126 and 127: Advantage of nanoparticles to deliv
- Page 128 and 129: The influence of hypoosmolar medium
- Page 130 and 131: Xanthohumol may affect cancer progr
- Page 132 and 133: List of participants Amberger Murph
- Page 134 and 135: Genova Kalou Petia National Center
- Page 136 and 137: Korolenko Tatiana Institute of Phys
- Page 138 and 139: Opolon Paule Institut Gustave-Rouss
- Page 140 and 141: Sedmak Bojan National Institute of
- Page 142 and 143: Voulgari Angeliki National Hellenic
- Page 144 and 145: E Edwards Dylan 20 Edwards Dylan R.
- Page 148 and 149: We believe in our future! Photo: Ma
- Page 150 and 151: 150
- Page 152 and 153: 152
- Page 154 and 155: TANTUM VERDE 154
- Page 156 and 157: 156
- Page 158 and 159: 158